The senescence-associated secretory phenotype promotes benign prostatic hyperplasia
Paz Vital1, Patricia Castro1, Susan Tsang1
1Department of Pathology and Immunology, Baylor College of Medicine, and the Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas.
The American Journal of Pathology
|January 18, 2014
Summary
Senescence-associated secretory phenotype, characterized by increased cytokines, promotes benign prostatic hyperplasia (BPH) development. This age-related condition causes prostate tissue growth and urinary obstruction in older men.
Area of Science:
- Urology
- Gerontology
- Cell Biology
Background:
- Benign prostatic hyperplasia (BPH) is a common age-related condition causing prostate enlargement and urinary obstruction.
- Cellular senescence, marked by a senescence-associated secretory phenotype (SASP), increases with age and contributes to tissue dysfunction.
Purpose of the Study:
- To investigate the role of SASP in the development of benign prostatic hyperplasia.
- To explore the correlation between specific SASP cytokines and BPH severity.
Main Methods:
- Multiplex analysis of cytokines in BPH tissues and senescent cells.
- Immunohistochemistry (IHC) for senescence markers (cathepsin D) and cytokines (IL-1α).
- In vivo studies using tissue recombination and transgenic mouse models.
Main Results:
- Elevated levels of SASP cytokines (GM-CSF, IL-1α, IL-4) were found in BPH tissues and senescent cells.
- Cathepsin D, a senescence marker, correlated with prostate weight and IL-1α expression.
- IL-1α promoted epithelial and stromal cell growth in vitro and increased prostate size and bladder obstruction in vivo.
Conclusions:
- Correlative and functional data support the hypothesis that SASP drives benign prostatic hyperplasia development.
- Targeting SASP may offer a therapeutic strategy for this prevalent age-related pathology.
Related Concept Videos
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Replicative Cell Senescence
3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence
3.0K
3.0K
Cellular Adaptation III: Hyperplasia
55
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
55
Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K


